SlideShare uma empresa Scribd logo
1 de 15
Baixar para ler offline
Web Business Outline Presentation February 1, 2012
Millennium
Vascular & Cardio Care
Practice Management & Development Services
Coding Medical Devices ProCommBilling
OTC Pink: MHCC
MEDICAL PRACTICE MANAGEMENT SERVICES
Additional Services Provided:
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed herein are forward-looking
statements that involve a number of risks and uncertainties. The actual future results of Millennium
Healthcare, Inc.(the “Company”) could differ significantly from those statements. Factors that could
cause actual results to differ materially include risks and uncertainties such as the inability to finance the
company's operations or expansion, inability to hire and retain qualified personnel, changes in the
general economic climate, including rising interest rate and unanticipated events such as terrorist
activities.
In some cases, you can identify forward-looking statements by terminology such as "may," "will,"
"should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the
negative of such terms, or other comparable terminology. These statements are only predictions.
Although we believe that the expectations reflected in the forward-looking statements are reasonable,
such statements should not be regarded as a representation by the Company, or any other person, that
such forward-looking statements will be achieved, particularly if we have provided projected revenues
or forecasts, which are all simply estimates based on the opinions of management. We undertake no
duty to update any of the forward-looking statements, whether as a result of new information, future
events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such
forward-looking statements. For further risk factors see the risk factors associated with our Company,
please review our SEC filings
2
Millennium HealthCare strives to provide innovative
and effective practice management services to assist
Cardiology & Vascular specialists in growing their
practice. Our services enable the physician to offer their
patients top quality and convenient facility patient care
with greater comfort and ease for both doctor and
patient.
3
Primary Services Provided:
Vascular Management Services
• Medical practice management & development service for physician’s primarily focusing on
vascular disorders such as peripheral arterial disease (PAD) . These minimally invasive
procedures for (PAD) are performed by a highly skilled team of Interventional Cardiologist’s
and Vascular Surgeon’s who specialize in this care and treatment. Millennium Vascular
Management Group offers these physicians an alternative office based setting to enhance
patient care & comfort, physician flexibility and clinical outcome.
Cardiology Management Services
• The cardiology practice management & development service offers practitioners a flexible
business alternative to expand their patient retention and flow by providing advanced
cardiology care & testing capabilities within their existing office setting . Advanced
In-house services promotes long-term patient retention and revenue for their practice.
Additional Services Offered:
Billing Coding Medical Devices ProComm
4
Company Overview
Alternative-reporting OTC Pink : MHCC
Common Shares Outstanding a/o 11/30/11: 16,919,122
Current Market Capitalization @$1.25: $21,150,000
Additional information may be found at:
www.millenniumhcs.com & www.proactivenewsroom.com/mhcc
Disease and Stroke Statistics-2011 Update:
Most Costly Diseases
Cardio Vascular Diseases and stroke accounted for 15% of the total health expenditures in 2007. The total
cost and the indirect mortality cost estimates for CVD are higher than for any other major diagnostic group.
By way of comparison, CVD total direct and indirect costs are higher than the official National Cancer Institute
estimates for cancer and benign neoplasms in 2010, which were cited as $264 billion total, $103 billion direct,
$21 billion indirect morbidity, and $140 billion indirect cost of mortality.
Peripheral Arterial Disease
● Peripheral arterial disease (PAD) affects 8 million Americans and is associated with significant morbidity and
mortality. Prevalence increases dramatically with age, and PAD disproportionately affects blacks.
● PAD affects 12% to 20% of Americans 65 years of age. Despite its prevalence and cardiovascular risk implications,
only 70% to 80% of patients with PAD undergo recommended antiplatelet therapy or lipid-lowering therapy.
● In the general population, only 10% of people with PAD have the classic symptom of intermittent claudication.
Approximately 40% do not complain of leg pain, whereas the remaining 50% have a variety of leg symptoms different
from classic claudication. In an older, disabled population of women, however, as many as two thirds of individuals
with PAD had no exertional leg symptoms.ation and Costs
• on trends and current usage of cardiovascular surgical and invasive procedures shows the total number of inpatient
55
Industry Facts & Trends
Disease and Stroke Statistics-2011 Update:
Cardiovascular Procedure Utilization and Costs
Data on trends and current usage of cardiovascular surgical and invasive procedures shows the total
number of inpatient cardiovascular operations and procedures increased 27%, from 5,382 000 in 1997 to
6,846 000 in 2007 (National Heart, Lung, and Blood Institute computation based on National Center for
Health Statistics annual data). Reviews of current estimates of direct and indirect healthcare costs related
to Cardio Vascular Diseases (CVD), stroke, and related conditions using Medical Expenditure Panel Survey
data. The total direct and indirect cost of CVD and stroke in the United States for 2007 is estimated to be
$286 billion.
More information can be found at the National Center for Health Statistics Web
site,http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_01.pdf.
The online version of this article, along with updated information and services,
Is located on the World Wide Web at :http://circ.ahajournals.org/content/123/4/e18
6
Industry Facts & Trends
Vision
Our vision is to create a physician friendly business structure and combine it with experienced
dedicated health care professionals relentlessly committed to their patients. Our Practice
Management Group supports & manages cardio physician practices with an emphasis on the
diagnosis and treatment of Peripheral Arterial Disease (PAD) of the lower extremities. We
partner with top rated physicians skilled in the practice of Interventional Cardiology.
Vascular Surgery and Radiology.
7
Millennium Vascular & Cardio Care
Management Group
“About 10 million American adults have peripheral artery disease (PAD).
Although it was once believed that PAD occurs more often in men than women,
current research now indicates that both genders are equally susceptible.
African-Americans have twice the risk for PAD as Caucasians. Between 15 - 20%
of people over age 65 suffer from the condition.”
Millennium Vascular Management
Geographical Targets for 2012:
-Staten Island, New York
-Central New Jersey
-Southern New Jersey
-Florida
-Philadelphia, PA
-Atlanta
-Queens, New York
-Westchester, New York
Procedural Focus:
- Lower Extremity Arterial Diagnosis
- Catheter Placement
- Catheter Removal
- Venous PTA / Stent
- Arterial PTA
- Arterial Stent Placement
- Atherectomy
8
Business Development Strategy
• Experienced Management Team with significant outpatient cardiology & vascular
expertise.
• Identification of initial national footprint and access to highly skilled Interventionalists
• Current Marketplace ripe for expansion
• High Margin/Significant Cash-Flow Opportunity
• Current Insurance reimbursement favorable versus Hospital alternative
• Beneficial for Patient & Physician
9
Scheduled Opening - February- 2012
Millennium Vascular Management Group
of Staten Island
Millennium Cardio Care
Market Segment Strategic Advantages:
- Insurance Carriers pay for pre-cursor testing & minimally invasive medical
procedures to avoid long hospital stays and open procedures.
- target physicians in highly populated urban areas.
- Cardiology patient flow is a natural referral source for skilled Vascular Team.
- Cardio model offers many medical groups a flexible model to keep patients in house
with advanced cardio testing & physicians access.
Geographical Targets for 2012
-New York
-Florida
-New Jersey
-
10
Millennium Cardiology Management patient mix
represents a natural Internal Medicine / Referral
source for our entire network of Healthcare
Divisions. Cardio Management & Development
represents our first introduction to a cardio patient
that many be requiring more advanced care. Our
Vascular Group’s will be geographically located near
many Cardio locations to deliver patient comfort and
access to top-level Vascular physician’s.
Cardiology Service
-Initial patient evaluation & consultation
-EKG
-Echocardiogram
-Stress Echocardiogram
-Abdominal Aorta
-Renal Doppler
-Arterial Duplex
-Venous Duplex
-PVR
-Holter Monitoring
-ABI
-Exercise PVR
-Pulmonary Stress Test
-Nuclear Stress testing
-Cardiac PET
Additional Services Offered:
Coding Services
• Secure Remote or On-Site Coding
• ICD-10 Code Management
• Concurrent and Retrospective CDI Reviews
• DRG Validation Services
• DRG Reassignment Appeals
11
Billing Services
• Billing and Collections
• Electronic Medical Records
• Equipment Management
• Financing Services
• Lock-box management
ProComm Services
•Reliable Live Answering 24/7 Full Service Call Processing
•State of the Art Operating System with Call overflow Management
•Emergency Message / Dispatch
•Confidential Call Recording
•Receptionist Services and/or Voice Mail Messages & Screening
•Archive Message Services
•HIPAA Compliance / Training
•Never Down Environment (24 Hours a Day, 365 Days a Year)
Medical Devices
Test Kits :
• Cardiology Examinations
• Vascular Examinations
• Doctor’s Test Kit
MANAGEMENT TEAM
• Dominick Sartorio – CEO & Chairman of Millennium HealthCare Inc. served as Director of New Business for a Wall Street
management consulting firm, utilizing his expansive understanding of business strategy to spearhead the company’s continued
growth. As Director of New Business, he quickly employed his capabilities to the utmost degree, creating and implementing
initiatives for client companies’ worth up to $550 million in annual sales. Mr. Sartorio was placed as acting CEO of a global
technology firm, directing the research and development process, patent approval, product launch, and the negotiation of a 2-year,
$800 million sales agreement. Prior, Mr. Sartorio co-founded a highly successful manufacturing and distribution company
maintaining global reach in numerous industries such as medical, chemical and emerging technology markets. During his tenure, Mr.
Sartorio accomplished a great deal, vastly improving the profitability and cash flow of numerous holding companies and
implementing efficiencies, policies and procedures that had a global impact . Among Mr. Sartorio’s many achievements, the
development of the world’s largest synthetic vitamin B4 and antioxidant manufacturing facility is particularly of note. Under his
supervision and leadership, this facility produced in excess of 100 million pounds of product per year while remaining in compliance
with standards set forth by the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), the Occupational
Safety and Health Administration (OSHA) and the Drug Enforcement Agency (DEA).
• Chris Amandola – President & Director has more than 15 years of Professional Management, Senior Management and
Entrepreneurial experience in the Medical device arena. Chris has held positions at such high profiled Medical device Companies
like C.R. Bard Inc., Boston Scientific Corp. and Smith & Nephew Inc. Chris has experience and extensive knowledge in fields of
Peripheral Vascular, Coronary, Gastroenterology, Wound Care and Infection Control. Chris has worked closely and forged
relationships with key opinion leaders around the U.S. in each of these specialties. Mr. Amandola has provided strong executive
leadership including the management and direction of forecasting activities, budgeting, and successful market launch of new and
innovative products in the medical field. Chris has also negotiated and implemented key account contracts at many Major Health
Systems across the U.S. He has been responsible for managing the ongoing revenue and growth at all of these companies. Mr.
Amandola has excelled in organizing, training and executing sales distribution strategies for various medical products all within the
healthcare industry.
12
MANAGEMENT TEAM
• Anthony Urbano - Chief Financial Officer, Secretary & Director has over 18 years of forensic and financial accounting, finance,
administration, operational, sales/marketing budgets and projections, advisory and managerial experience in entrepreneurial and
high-growth companies. His experience comes from a variety of industries including, manufacturing, distribution, small cap / start-
ups, financial markets and financial data reporting, automotive, technology and media / entertainment. Mr. Urbano has provided
strong executive leadership for companies including the management and direction of cash/profitability forecasting activities,
budgeting, implementation of financial reporting structures, financial analyses, evaluation and recommendations of company
information systems, sales and marketing initiatives, audit support, infrastructures, traditional and alternative financing,
information technology, cost and debt reduction initiatives, restructuring and strategic planning.
Mr. Urbano also has extensive experience in managing reporting, compliance and issue resolutions for government regulatory
bodies including departments of corporations, departments of labor, departments of taxation and most phases of SEC reporting
(pre-SOX), including 10-Q, 10-K, 8-K, delisting, relisting, commentary periods (textual and accounting), NASDAQ OTC and BB status
and inquiries/investigations. He also has executed the planning, design and implementation of complete human resource /
employee benefit and retirement initiatives, information technology infrastructures and corporate/commercial risk management.
• Richard DeMaio – Chief Information Officer is currently the President of Heartbeat Medical PC, an AMSURG-Cardiology Center and
Management Services Organization that provides a full suite of consulting services to private practices, AMSURG facilities and
hospitals. Heartbeat is a related subsidiary of Premier HealthCare Resources, one of the largest providers of cardiovascular services
in the New York area with over 30 locations under management. Mr. DeMaio has over 15 years of superior experience in the
healthcare industry, commanding senior level executive positions with Long Island Jewish Medical Center, Brookdale Hospital
Medical Center and Sonix Medical Resources. His experience comes from a variety of administration and operations management
including renovation and expansion of facilities, development and implementation of centers, Federal and State Departments of
Health and Public Council Compliance, development, implementation and seamless integration of new products/services and overall
effective and efficient medical and physician practice development and management.
13
ADVISORY BOARD MEMBERS
• Marc Sherman, MD FACC currently serves as the Medical Director of Heartbeat Medical PC and is also an active member with
Medical Health Associates of Bellerose, DOC Care, Midtown Internal Medicine, R and L Medical Associates and Total Medical PC. Dr.
Sherman also currently serves as attending staff/medical staff physician at NYU Hospital, St. Luke’s/Roosevelt Hospital and St John’s
Medical Center. Dr. Sherman is Board Certified from the American Board of Internal Medicine for Internal Medicine and
Cardiovascular Disease, and holds an active license to practice medicine in the State of New York.
• Elias Zias, MD currently serves as attending physician at St. John’s Medical Center, St. Joseph’s Medical Center, Community Hospital
at Dobbs Ferry, Hudson Valley Hospital Center and NY School of Medicine NYU Langone Medical Center. Dr. Zias also holds an
academic appointment as Clinical Associate Professor at the NYU School of Medicine, holds fellowships with the American College of
Cardiology and the American College of Surgeons and has been published numerous times. Dr. Zias is Board Certified from the
American Board of Surgery and the American Board of Thoracic Surgery, and holds an active license to practice medicine in the
States of New York, Connecticut and Illinois.
• Edward Joyce – Vice President of Sales and Marketing - has over 17 years experience in medical sales and medical sales
management. Edward has spent time with and has a long history of success with leading medical device manufacturers such as C.R.
Bard Inc., Edwards Life sciences and St. Jude Medical. His expertise includes but is not limited to managing as well as building
professional sales organizations. Throughout Edward’s tenure he has called on numerous areas of hospitals including Infection
Control, Housekeeping, Cardiology, Radiology, ICU’s as well as the Operating Room. In each of these departments Edward has built
tremendous relationships across the United States and brings with him a large network of KOL’s in each of these areas. Edward has
also successfully managed to launch a variety of new technology in each of the aforementioned hospital departments in which he
had a key role in both sales related and marketing related strategies.
• Mark Allen – Southeast Regional Director of Sales- Mr. Allen has close to 20 years of Medical device sales, sales management and
medical recruiting. Mark has held positions at some of the premiere medical device companies in the industry, Stryker, Inamed,
Abbot Vascular, to name a few. Mr. Allen’s comes to Millennium after being the Director of Business Development for Vascular
Access Centers (VAC). Mark developed relationships with the top physicians domestically in the fields of Interventional Cardiology,
Interventional Radiology and Vascular Surgery. He was instrumental in their recruitment, contractual obligation, ownership and
driving revenue. In the last 12 months he's been responsible for recruiting and signing 15 physicians to 6 new centers. This included
and not limited to the negotiating of real estate, employees, marketing, equipment, and all start up costs involved. Mark has
successfully negotiated contract with all the medical device manufactures and distributors associated with these centers.
14
15 15
Heart Disease & Stoke Statistics - 2011

Mais conteúdo relacionado

Mais procurados

Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
Conifer Health Solutions
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation
ir_stjude
 
2014 Investor Day Conference
2014 Investor Day Conference2014 Investor Day Conference
2014 Investor Day Conference
ir_stjude
 
Coordinating an ECMO service with retrieval by Dr Shay McGuinness
Coordinating an ECMO service with retrieval by Dr Shay McGuinnessCoordinating an ECMO service with retrieval by Dr Shay McGuinness
Coordinating an ECMO service with retrieval by Dr Shay McGuinness
CICM 2019 Annual Scientific Meeting
 
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving NetworksCISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
Steven Wardell
 

Mais procurados (20)

Ahi investor presentation deck march 2017
Ahi investor presentation deck   march 2017Ahi investor presentation deck   march 2017
Ahi investor presentation deck march 2017
 
How HCC Coding Works?
How HCC Coding Works? How HCC Coding Works?
How HCC Coding Works?
 
OM(I)G! New York Medicaid Case Mix Audit Success
OM(I)G! New York Medicaid Case Mix Audit SuccessOM(I)G! New York Medicaid Case Mix Audit Success
OM(I)G! New York Medicaid Case Mix Audit Success
 
Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
Creating Data-driven Strategies to Improve Hospital Outcomes: A Case Manager'...
 
2016 analyst and investor day presentation
2016 analyst and investor day presentation2016 analyst and investor day presentation
2016 analyst and investor day presentation
 
2015 investor's meeting consolidated slide deck final
2015 investor's meeting consolidated slide deck final2015 investor's meeting consolidated slide deck final
2015 investor's meeting consolidated slide deck final
 
Guidelines for the primary prevention of stroke
Guidelines for the primary prevention of strokeGuidelines for the primary prevention of stroke
Guidelines for the primary prevention of stroke
 
Ahi deck march 2017 r
Ahi deck   march 2017 rAhi deck   march 2017 r
Ahi deck march 2017 r
 
St. Jude Medical 2015 Annual Investor Meeting Presentation
St. Jude Medical 2015 Annual Investor Meeting PresentationSt. Jude Medical 2015 Annual Investor Meeting Presentation
St. Jude Medical 2015 Annual Investor Meeting Presentation
 
2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation2016 analyst and investor meeting presentation
2016 analyst and investor meeting presentation
 
2014 Investor Day Conference
2014 Investor Day Conference2014 Investor Day Conference
2014 Investor Day Conference
 
Ahi deck march 2017 r2
Ahi deck   march 2017 r2Ahi deck   march 2017 r2
Ahi deck march 2017 r2
 
Coordinating an ECMO service with retrieval by Dr Shay McGuinness
Coordinating an ECMO service with retrieval by Dr Shay McGuinnessCoordinating an ECMO service with retrieval by Dr Shay McGuinness
Coordinating an ECMO service with retrieval by Dr Shay McGuinness
 
The Top Ten Issues in Physician Practice Acquisition and Valuation
The Top Ten Issues in Physician Practice Acquisition and ValuationThe Top Ten Issues in Physician Practice Acquisition and Valuation
The Top Ten Issues in Physician Practice Acquisition and Valuation
 
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving NetworksCISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
CISummit: Zach Henderson, Data-tastick: A Deep Dive on Data Driving Networks
 
Financial and Bond Services for Hospital Market
Financial and Bond Services for Hospital MarketFinancial and Bond Services for Hospital Market
Financial and Bond Services for Hospital Market
 
Prevention of stroke in patients with tia
Prevention of stroke in patients with tiaPrevention of stroke in patients with tia
Prevention of stroke in patients with tia
 
Ensuring Accurate HCC Coding and Documentation
Ensuring Accurate HCC Coding and Documentation Ensuring Accurate HCC Coding and Documentation
Ensuring Accurate HCC Coding and Documentation
 
How Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam KassingHow Healthcare Reform Is Affecting Radiology, Pam Kassing
How Healthcare Reform Is Affecting Radiology, Pam Kassing
 
Office based Surgery
Office based SurgeryOffice based Surgery
Office based Surgery
 

Destaque

Soal bahasa indonesia
Soal bahasa indonesiaSoal bahasa indonesia
Soal bahasa indonesia
Naya Ti
 
Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites
ProActive Capital Resources Group
 
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клубаtweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
Бициклистички клуб ГОРСКИ
 
Pyramid (GROUP 3)
Pyramid (GROUP 3)Pyramid (GROUP 3)
Pyramid (GROUP 3)
asita warda
 
Evaluation 3
Evaluation 3Evaluation 3
Evaluation 3
EDPRICE93
 

Destaque (20)

Eo ct speech feb 2014
Eo ct speech feb 2014Eo ct speech feb 2014
Eo ct speech feb 2014
 
Intellipharmaceutics Corporate Presentation, February 2012
Intellipharmaceutics Corporate Presentation, February 2012Intellipharmaceutics Corporate Presentation, February 2012
Intellipharmaceutics Corporate Presentation, February 2012
 
No1
No1No1
No1
 
Soal bahasa indonesia
Soal bahasa indonesiaSoal bahasa indonesia
Soal bahasa indonesia
 
Pegasi Energy Research Note July 18, 2012
Pegasi Energy Research Note July 18, 2012Pegasi Energy Research Note July 18, 2012
Pegasi Energy Research Note July 18, 2012
 
Ad van Wijk, Energietransitie, 26-10-2011
Ad van Wijk, Energietransitie, 26-10-2011Ad van Wijk, Energietransitie, 26-10-2011
Ad van Wijk, Energietransitie, 26-10-2011
 
環境コミュニケーションをデザインする。
環境コミュニケーションをデザインする。環境コミュニケーションをデザインする。
環境コミュニケーションをデザインする。
 
Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites Neostem Research Report by JMP Securites
Neostem Research Report by JMP Securites
 
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
InVivo Therapeutics Holdings Corp. (ONVIV.OB)InVivo Therapeutics Holdings Corp. (ONVIV.OB)
InVivo Therapeutics Holdings Corp. (ONVIV.OB)
 
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
Fibrocell Science ($FCSC) - Rodman & Renshaw 2011
 
Business intelligence
Business intelligenceBusiness intelligence
Business intelligence
 
Law 1102
Law 1102Law 1102
Law 1102
 
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клубаtweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
tweetbook: Digitalna hronika kluba 5/2010 - 10/2014 Дигитална хроника клуба
 
Pyramid (GROUP 3)
Pyramid (GROUP 3)Pyramid (GROUP 3)
Pyramid (GROUP 3)
 
Peter Slavenburg, Northernlight: Creative Transmission #4 15 september 2011
Peter Slavenburg, Northernlight: Creative Transmission #4 15 september 2011Peter Slavenburg, Northernlight: Creative Transmission #4 15 september 2011
Peter Slavenburg, Northernlight: Creative Transmission #4 15 september 2011
 
Evaluation 3
Evaluation 3Evaluation 3
Evaluation 3
 
3 reports
3 reports3 reports
3 reports
 
Kaihan aba march 2014
Kaihan aba march 2014Kaihan aba march 2014
Kaihan aba march 2014
 
Innovatie in de Sierteelt & het Businessmodel, door Marcel Claessen, 16 nov 2011
Innovatie in de Sierteelt & het Businessmodel, door Marcel Claessen, 16 nov 2011Innovatie in de Sierteelt & het Businessmodel, door Marcel Claessen, 16 nov 2011
Innovatie in de Sierteelt & het Businessmodel, door Marcel Claessen, 16 nov 2011
 
FrontEnd Conf Zurich 2013
FrontEnd Conf Zurich 2013FrontEnd Conf Zurich 2013
FrontEnd Conf Zurich 2013
 

Semelhante a 2012 MHCC Web Presentation Proposal-Feb 2

Wearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac RehabilitationWearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac Rehabilitation
Ashot Melik-Martirosian
 
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docx
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docxNicholas E. Davies Enterprise Award of Excellence Clinical V.docx
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docx
curwenmichaela
 
mHealth for providers in India
mHealth for providers in IndiamHealth for providers in India
mHealth for providers in India
HELATHCURSOR CONSULTING GROUP
 
Multi-Disciplinary Renal Clinic Presentation to Exec Leadership
Multi-Disciplinary Renal Clinic Presentation to Exec LeadershipMulti-Disciplinary Renal Clinic Presentation to Exec Leadership
Multi-Disciplinary Renal Clinic Presentation to Exec Leadership
TJ O'Neil
 
Stfm april 28 2011
Stfm april 28 2011Stfm april 28 2011
Stfm april 28 2011
Paul Grundy
 
1- Talk more about the industry background half a page !In.docx
1- Talk more about the industry background half a page !In.docx1- Talk more about the industry background half a page !In.docx
1- Talk more about the industry background half a page !In.docx
SONU61709
 

Semelhante a 2012 MHCC Web Presentation Proposal-Feb 2 (20)

Wearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac RehabilitationWearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac Rehabilitation
 
MHCC Web Business Plan 12 20-2011
MHCC Web Business Plan 12 20-2011MHCC Web Business Plan 12 20-2011
MHCC Web Business Plan 12 20-2011
 
Cytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocpCytori mar-2015 final-mh-v001_d5aocp
Cytori mar-2015 final-mh-v001_d5aocp
 
The Heartaches Associated with Billing for Cardiac Devices
The Heartaches Associated with Billing for Cardiac DevicesThe Heartaches Associated with Billing for Cardiac Devices
The Heartaches Associated with Billing for Cardiac Devices
 
Miles Snowden, MD - Prevention, Wellness & Outcomes from a Payer Prospective
Miles Snowden, MD - Prevention, Wellness & Outcomes from a Payer ProspectiveMiles Snowden, MD - Prevention, Wellness & Outcomes from a Payer Prospective
Miles Snowden, MD - Prevention, Wellness & Outcomes from a Payer Prospective
 
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docx
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docxNicholas E. Davies Enterprise Award of Excellence Clinical V.docx
Nicholas E. Davies Enterprise Award of Excellence Clinical V.docx
 
The Hidden Truths in Inpatient Documentation that Physicians Can Uncover-Trac...
The Hidden Truths in Inpatient Documentation that Physicians Can Uncover-Trac...The Hidden Truths in Inpatient Documentation that Physicians Can Uncover-Trac...
The Hidden Truths in Inpatient Documentation that Physicians Can Uncover-Trac...
 
mHealth for providers in India
mHealth for providers in IndiamHealth for providers in India
mHealth for providers in India
 
All You Need to Know About Cardiology Billing.pdf
All You Need to Know About Cardiology Billing.pdfAll You Need to Know About Cardiology Billing.pdf
All You Need to Know About Cardiology Billing.pdf
 
All You Need to Know About Cardiology Billing.pptx
All You Need to Know About Cardiology Billing.pptxAll You Need to Know About Cardiology Billing.pptx
All You Need to Know About Cardiology Billing.pptx
 
Leveraging Data And Strong Partnerships To Thrive In The Land Between Volume ...
Leveraging Data And Strong Partnerships To Thrive In The Land Between Volume ...Leveraging Data And Strong Partnerships To Thrive In The Land Between Volume ...
Leveraging Data And Strong Partnerships To Thrive In The Land Between Volume ...
 
hospitalGuide2007
hospitalGuide2007hospitalGuide2007
hospitalGuide2007
 
Multi-Disciplinary Renal Clinic Presentation to Exec Leadership
Multi-Disciplinary Renal Clinic Presentation to Exec LeadershipMulti-Disciplinary Renal Clinic Presentation to Exec Leadership
Multi-Disciplinary Renal Clinic Presentation to Exec Leadership
 
Six Ways Health Systems Use Analytics to Improve Patient Safety
Six Ways Health Systems Use Analytics to Improve Patient SafetySix Ways Health Systems Use Analytics to Improve Patient Safety
Six Ways Health Systems Use Analytics to Improve Patient Safety
 
Sepsis and Post-Sepsis Syndrome
Sepsis and Post-Sepsis SyndromeSepsis and Post-Sepsis Syndrome
Sepsis and Post-Sepsis Syndrome
 
Investor Present 04202017
Investor Present  04202017Investor Present  04202017
Investor Present 04202017
 
Stfm april 28 2011
Stfm april 28 2011Stfm april 28 2011
Stfm april 28 2011
 
1- Talk more about the industry background half a page !In.docx
1- Talk more about the industry background half a page !In.docx1- Talk more about the industry background half a page !In.docx
1- Talk more about the industry background half a page !In.docx
 
Dealing With Payers With Physician Driven Cost And
Dealing With Payers With Physician Driven Cost AndDealing With Payers With Physician Driven Cost And
Dealing With Payers With Physician Driven Cost And
 
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2015
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2015Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2015
Mercer Capital's Value Focus: Healthcare Facilities | Mid-Year 2015
 

Mais de ProActive Capital Resources Group

Mais de ProActive Capital Resources Group (20)

Islet defense in bio century week of 5 28-12
Islet defense in bio century week of 5 28-12Islet defense in bio century week of 5 28-12
Islet defense in bio century week of 5 28-12
 
Insider transaction detail for Isa Odidi (IPCI)
Insider transaction detail for Isa Odidi (IPCI)Insider transaction detail for Isa Odidi (IPCI)
Insider transaction detail for Isa Odidi (IPCI)
 
Caprock risk management, llc
Caprock risk management, llcCaprock risk management, llc
Caprock risk management, llc
 
VTUS SEC Filing Form 8-K
VTUS SEC Filing Form 8-KVTUS SEC Filing Form 8-K
VTUS SEC Filing Form 8-K
 
TNXP Fact Sheet May 2012
TNXP Fact Sheet May 2012TNXP Fact Sheet May 2012
TNXP Fact Sheet May 2012
 
Arcis Exec Summary
Arcis Exec Summary Arcis Exec Summary
Arcis Exec Summary
 
SSIE 4.20.12
SSIE 4.20.12 SSIE 4.20.12
SSIE 4.20.12
 
Kerx zerenex phase3
Kerx zerenex phase3Kerx zerenex phase3
Kerx zerenex phase3
 
ARM Stroke
ARM StrokeARM Stroke
ARM Stroke
 
ARM Parkinsons
ARM ParkinsonsARM Parkinsons
ARM Parkinsons
 
ARM Heart Disease
ARM Heart DiseaseARM Heart Disease
ARM Heart Disease
 
ARM Diabetes
ARM DiabetesARM Diabetes
ARM Diabetes
 
Arm ALS
Arm ALSArm ALS
Arm ALS
 
Tonix12 ceocfo-article-clean newphoto
Tonix12 ceocfo-article-clean newphotoTonix12 ceocfo-article-clean newphoto
Tonix12 ceocfo-article-clean newphoto
 
Applied DNA Sciences (OTCBB: APDN)
Applied DNA Sciences (OTCBB: APDN)Applied DNA Sciences (OTCBB: APDN)
Applied DNA Sciences (OTCBB: APDN)
 
Daily Dose Equities - Intracoronary Bone Marrow
Daily Dose Equities - Intracoronary Bone MarrowDaily Dose Equities - Intracoronary Bone Marrow
Daily Dose Equities - Intracoronary Bone Marrow
 
Daily Dose Equities - Effect of Transendocardial Delivery
Daily Dose Equities - Effect of Transendocardial Delivery Daily Dose Equities - Effect of Transendocardial Delivery
Daily Dose Equities - Effect of Transendocardial Delivery
 
Daily Dose Equities - Exosomes from human cd34
Daily Dose Equities - Exosomes from human cd34Daily Dose Equities - Exosomes from human cd34
Daily Dose Equities - Exosomes from human cd34
 
2012 MHCC Web resentation proposal-3-19-2012-published
2012 MHCC Web resentation proposal-3-19-2012-published2012 MHCC Web resentation proposal-3-19-2012-published
2012 MHCC Web resentation proposal-3-19-2012-published
 
PolyMedix ($PYMX) Cowan Research
PolyMedix ($PYMX) Cowan Research PolyMedix ($PYMX) Cowan Research
PolyMedix ($PYMX) Cowan Research
 

Último

Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Klinik kandungan
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
sovco
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
Terna SpA
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
xzxvi5zp
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
Probe Gold
 

Último (20)

Osisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 ResultsOsisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 Results
 
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
 
Teekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings ResultsTeekay Corporation Q1-24 Earnings Results
Teekay Corporation Q1-24 Earnings Results
 
countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
 
Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
 
Teekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings Presentation
 
SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024
 
Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024
 
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdfITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
 
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In DubaiDubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024
 
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
一比一原版(Acadia毕业证书)加拿大阿卡迪亚大学毕业证学历认证可查认证
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 Presentation
 
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call GirlsPremium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
 

2012 MHCC Web Presentation Proposal-Feb 2

  • 1. Web Business Outline Presentation February 1, 2012 Millennium Vascular & Cardio Care Practice Management & Development Services Coding Medical Devices ProCommBilling OTC Pink: MHCC MEDICAL PRACTICE MANAGEMENT SERVICES Additional Services Provided:
  • 2. Safe Harbor Statement Under the Private Securities Litigation Act of 1995 With the exception of historical information, the matters discussed herein are forward-looking statements that involve a number of risks and uncertainties. The actual future results of Millennium Healthcare, Inc.(the “Company”) could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rate and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved, particularly if we have provided projected revenues or forecasts, which are all simply estimates based on the opinions of management. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors see the risk factors associated with our Company, please review our SEC filings 2
  • 3. Millennium HealthCare strives to provide innovative and effective practice management services to assist Cardiology & Vascular specialists in growing their practice. Our services enable the physician to offer their patients top quality and convenient facility patient care with greater comfort and ease for both doctor and patient. 3
  • 4. Primary Services Provided: Vascular Management Services • Medical practice management & development service for physician’s primarily focusing on vascular disorders such as peripheral arterial disease (PAD) . These minimally invasive procedures for (PAD) are performed by a highly skilled team of Interventional Cardiologist’s and Vascular Surgeon’s who specialize in this care and treatment. Millennium Vascular Management Group offers these physicians an alternative office based setting to enhance patient care & comfort, physician flexibility and clinical outcome. Cardiology Management Services • The cardiology practice management & development service offers practitioners a flexible business alternative to expand their patient retention and flow by providing advanced cardiology care & testing capabilities within their existing office setting . Advanced In-house services promotes long-term patient retention and revenue for their practice. Additional Services Offered: Billing Coding Medical Devices ProComm 4 Company Overview Alternative-reporting OTC Pink : MHCC Common Shares Outstanding a/o 11/30/11: 16,919,122 Current Market Capitalization @$1.25: $21,150,000 Additional information may be found at: www.millenniumhcs.com & www.proactivenewsroom.com/mhcc
  • 5. Disease and Stroke Statistics-2011 Update: Most Costly Diseases Cardio Vascular Diseases and stroke accounted for 15% of the total health expenditures in 2007. The total cost and the indirect mortality cost estimates for CVD are higher than for any other major diagnostic group. By way of comparison, CVD total direct and indirect costs are higher than the official National Cancer Institute estimates for cancer and benign neoplasms in 2010, which were cited as $264 billion total, $103 billion direct, $21 billion indirect morbidity, and $140 billion indirect cost of mortality. Peripheral Arterial Disease ● Peripheral arterial disease (PAD) affects 8 million Americans and is associated with significant morbidity and mortality. Prevalence increases dramatically with age, and PAD disproportionately affects blacks. ● PAD affects 12% to 20% of Americans 65 years of age. Despite its prevalence and cardiovascular risk implications, only 70% to 80% of patients with PAD undergo recommended antiplatelet therapy or lipid-lowering therapy. ● In the general population, only 10% of people with PAD have the classic symptom of intermittent claudication. Approximately 40% do not complain of leg pain, whereas the remaining 50% have a variety of leg symptoms different from classic claudication. In an older, disabled population of women, however, as many as two thirds of individuals with PAD had no exertional leg symptoms.ation and Costs • on trends and current usage of cardiovascular surgical and invasive procedures shows the total number of inpatient 55 Industry Facts & Trends
  • 6. Disease and Stroke Statistics-2011 Update: Cardiovascular Procedure Utilization and Costs Data on trends and current usage of cardiovascular surgical and invasive procedures shows the total number of inpatient cardiovascular operations and procedures increased 27%, from 5,382 000 in 1997 to 6,846 000 in 2007 (National Heart, Lung, and Blood Institute computation based on National Center for Health Statistics annual data). Reviews of current estimates of direct and indirect healthcare costs related to Cardio Vascular Diseases (CVD), stroke, and related conditions using Medical Expenditure Panel Survey data. The total direct and indirect cost of CVD and stroke in the United States for 2007 is estimated to be $286 billion. More information can be found at the National Center for Health Statistics Web site,http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_01.pdf. The online version of this article, along with updated information and services, Is located on the World Wide Web at :http://circ.ahajournals.org/content/123/4/e18 6 Industry Facts & Trends
  • 7. Vision Our vision is to create a physician friendly business structure and combine it with experienced dedicated health care professionals relentlessly committed to their patients. Our Practice Management Group supports & manages cardio physician practices with an emphasis on the diagnosis and treatment of Peripheral Arterial Disease (PAD) of the lower extremities. We partner with top rated physicians skilled in the practice of Interventional Cardiology. Vascular Surgery and Radiology. 7 Millennium Vascular & Cardio Care Management Group “About 10 million American adults have peripheral artery disease (PAD). Although it was once believed that PAD occurs more often in men than women, current research now indicates that both genders are equally susceptible. African-Americans have twice the risk for PAD as Caucasians. Between 15 - 20% of people over age 65 suffer from the condition.”
  • 8. Millennium Vascular Management Geographical Targets for 2012: -Staten Island, New York -Central New Jersey -Southern New Jersey -Florida -Philadelphia, PA -Atlanta -Queens, New York -Westchester, New York Procedural Focus: - Lower Extremity Arterial Diagnosis - Catheter Placement - Catheter Removal - Venous PTA / Stent - Arterial PTA - Arterial Stent Placement - Atherectomy 8 Business Development Strategy • Experienced Management Team with significant outpatient cardiology & vascular expertise. • Identification of initial national footprint and access to highly skilled Interventionalists • Current Marketplace ripe for expansion • High Margin/Significant Cash-Flow Opportunity • Current Insurance reimbursement favorable versus Hospital alternative • Beneficial for Patient & Physician
  • 9. 9 Scheduled Opening - February- 2012 Millennium Vascular Management Group of Staten Island
  • 10. Millennium Cardio Care Market Segment Strategic Advantages: - Insurance Carriers pay for pre-cursor testing & minimally invasive medical procedures to avoid long hospital stays and open procedures. - target physicians in highly populated urban areas. - Cardiology patient flow is a natural referral source for skilled Vascular Team. - Cardio model offers many medical groups a flexible model to keep patients in house with advanced cardio testing & physicians access. Geographical Targets for 2012 -New York -Florida -New Jersey - 10 Millennium Cardiology Management patient mix represents a natural Internal Medicine / Referral source for our entire network of Healthcare Divisions. Cardio Management & Development represents our first introduction to a cardio patient that many be requiring more advanced care. Our Vascular Group’s will be geographically located near many Cardio locations to deliver patient comfort and access to top-level Vascular physician’s. Cardiology Service -Initial patient evaluation & consultation -EKG -Echocardiogram -Stress Echocardiogram -Abdominal Aorta -Renal Doppler -Arterial Duplex -Venous Duplex -PVR -Holter Monitoring -ABI -Exercise PVR -Pulmonary Stress Test -Nuclear Stress testing -Cardiac PET
  • 11. Additional Services Offered: Coding Services • Secure Remote or On-Site Coding • ICD-10 Code Management • Concurrent and Retrospective CDI Reviews • DRG Validation Services • DRG Reassignment Appeals 11 Billing Services • Billing and Collections • Electronic Medical Records • Equipment Management • Financing Services • Lock-box management ProComm Services •Reliable Live Answering 24/7 Full Service Call Processing •State of the Art Operating System with Call overflow Management •Emergency Message / Dispatch •Confidential Call Recording •Receptionist Services and/or Voice Mail Messages & Screening •Archive Message Services •HIPAA Compliance / Training •Never Down Environment (24 Hours a Day, 365 Days a Year) Medical Devices Test Kits : • Cardiology Examinations • Vascular Examinations • Doctor’s Test Kit
  • 12. MANAGEMENT TEAM • Dominick Sartorio – CEO & Chairman of Millennium HealthCare Inc. served as Director of New Business for a Wall Street management consulting firm, utilizing his expansive understanding of business strategy to spearhead the company’s continued growth. As Director of New Business, he quickly employed his capabilities to the utmost degree, creating and implementing initiatives for client companies’ worth up to $550 million in annual sales. Mr. Sartorio was placed as acting CEO of a global technology firm, directing the research and development process, patent approval, product launch, and the negotiation of a 2-year, $800 million sales agreement. Prior, Mr. Sartorio co-founded a highly successful manufacturing and distribution company maintaining global reach in numerous industries such as medical, chemical and emerging technology markets. During his tenure, Mr. Sartorio accomplished a great deal, vastly improving the profitability and cash flow of numerous holding companies and implementing efficiencies, policies and procedures that had a global impact . Among Mr. Sartorio’s many achievements, the development of the world’s largest synthetic vitamin B4 and antioxidant manufacturing facility is particularly of note. Under his supervision and leadership, this facility produced in excess of 100 million pounds of product per year while remaining in compliance with standards set forth by the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA) and the Drug Enforcement Agency (DEA). • Chris Amandola – President & Director has more than 15 years of Professional Management, Senior Management and Entrepreneurial experience in the Medical device arena. Chris has held positions at such high profiled Medical device Companies like C.R. Bard Inc., Boston Scientific Corp. and Smith & Nephew Inc. Chris has experience and extensive knowledge in fields of Peripheral Vascular, Coronary, Gastroenterology, Wound Care and Infection Control. Chris has worked closely and forged relationships with key opinion leaders around the U.S. in each of these specialties. Mr. Amandola has provided strong executive leadership including the management and direction of forecasting activities, budgeting, and successful market launch of new and innovative products in the medical field. Chris has also negotiated and implemented key account contracts at many Major Health Systems across the U.S. He has been responsible for managing the ongoing revenue and growth at all of these companies. Mr. Amandola has excelled in organizing, training and executing sales distribution strategies for various medical products all within the healthcare industry. 12
  • 13. MANAGEMENT TEAM • Anthony Urbano - Chief Financial Officer, Secretary & Director has over 18 years of forensic and financial accounting, finance, administration, operational, sales/marketing budgets and projections, advisory and managerial experience in entrepreneurial and high-growth companies. His experience comes from a variety of industries including, manufacturing, distribution, small cap / start- ups, financial markets and financial data reporting, automotive, technology and media / entertainment. Mr. Urbano has provided strong executive leadership for companies including the management and direction of cash/profitability forecasting activities, budgeting, implementation of financial reporting structures, financial analyses, evaluation and recommendations of company information systems, sales and marketing initiatives, audit support, infrastructures, traditional and alternative financing, information technology, cost and debt reduction initiatives, restructuring and strategic planning. Mr. Urbano also has extensive experience in managing reporting, compliance and issue resolutions for government regulatory bodies including departments of corporations, departments of labor, departments of taxation and most phases of SEC reporting (pre-SOX), including 10-Q, 10-K, 8-K, delisting, relisting, commentary periods (textual and accounting), NASDAQ OTC and BB status and inquiries/investigations. He also has executed the planning, design and implementation of complete human resource / employee benefit and retirement initiatives, information technology infrastructures and corporate/commercial risk management. • Richard DeMaio – Chief Information Officer is currently the President of Heartbeat Medical PC, an AMSURG-Cardiology Center and Management Services Organization that provides a full suite of consulting services to private practices, AMSURG facilities and hospitals. Heartbeat is a related subsidiary of Premier HealthCare Resources, one of the largest providers of cardiovascular services in the New York area with over 30 locations under management. Mr. DeMaio has over 15 years of superior experience in the healthcare industry, commanding senior level executive positions with Long Island Jewish Medical Center, Brookdale Hospital Medical Center and Sonix Medical Resources. His experience comes from a variety of administration and operations management including renovation and expansion of facilities, development and implementation of centers, Federal and State Departments of Health and Public Council Compliance, development, implementation and seamless integration of new products/services and overall effective and efficient medical and physician practice development and management. 13
  • 14. ADVISORY BOARD MEMBERS • Marc Sherman, MD FACC currently serves as the Medical Director of Heartbeat Medical PC and is also an active member with Medical Health Associates of Bellerose, DOC Care, Midtown Internal Medicine, R and L Medical Associates and Total Medical PC. Dr. Sherman also currently serves as attending staff/medical staff physician at NYU Hospital, St. Luke’s/Roosevelt Hospital and St John’s Medical Center. Dr. Sherman is Board Certified from the American Board of Internal Medicine for Internal Medicine and Cardiovascular Disease, and holds an active license to practice medicine in the State of New York. • Elias Zias, MD currently serves as attending physician at St. John’s Medical Center, St. Joseph’s Medical Center, Community Hospital at Dobbs Ferry, Hudson Valley Hospital Center and NY School of Medicine NYU Langone Medical Center. Dr. Zias also holds an academic appointment as Clinical Associate Professor at the NYU School of Medicine, holds fellowships with the American College of Cardiology and the American College of Surgeons and has been published numerous times. Dr. Zias is Board Certified from the American Board of Surgery and the American Board of Thoracic Surgery, and holds an active license to practice medicine in the States of New York, Connecticut and Illinois. • Edward Joyce – Vice President of Sales and Marketing - has over 17 years experience in medical sales and medical sales management. Edward has spent time with and has a long history of success with leading medical device manufacturers such as C.R. Bard Inc., Edwards Life sciences and St. Jude Medical. His expertise includes but is not limited to managing as well as building professional sales organizations. Throughout Edward’s tenure he has called on numerous areas of hospitals including Infection Control, Housekeeping, Cardiology, Radiology, ICU’s as well as the Operating Room. In each of these departments Edward has built tremendous relationships across the United States and brings with him a large network of KOL’s in each of these areas. Edward has also successfully managed to launch a variety of new technology in each of the aforementioned hospital departments in which he had a key role in both sales related and marketing related strategies. • Mark Allen – Southeast Regional Director of Sales- Mr. Allen has close to 20 years of Medical device sales, sales management and medical recruiting. Mark has held positions at some of the premiere medical device companies in the industry, Stryker, Inamed, Abbot Vascular, to name a few. Mr. Allen’s comes to Millennium after being the Director of Business Development for Vascular Access Centers (VAC). Mark developed relationships with the top physicians domestically in the fields of Interventional Cardiology, Interventional Radiology and Vascular Surgery. He was instrumental in their recruitment, contractual obligation, ownership and driving revenue. In the last 12 months he's been responsible for recruiting and signing 15 physicians to 6 new centers. This included and not limited to the negotiating of real estate, employees, marketing, equipment, and all start up costs involved. Mark has successfully negotiated contract with all the medical device manufactures and distributors associated with these centers. 14
  • 15. 15 15 Heart Disease & Stoke Statistics - 2011